Aarti Pharmalabs Ltd announced its Q1 FY26 Results Presentation, which includes information about their global market share and financial performance metrics such as revenue and EBITDA margins. The presentation was filed on August 13, 2025 under Regulation 30 of SEBI (LODR) regulations.